Exact Sciences Corporation

EXAS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
2,759
Cost of Revenue
840
Gross Profit
1,919
Gross Margin
69.5%
Operating Income
-1,049
Operating Margin
-38.0%
Net Income
-1,029
Net Margin
-37.3%
EPS (Basic)
$-5.59
EPS (Diluted)
$-5.59
EBITDA
-789
EBITDA Margin
-28.6%

2023

12/31/2023

Revenue
2,500
Cost of Revenue
654
Gross Profit
1,846
Gross Margin
73.8%
Operating Income
-215
Operating Margin
-8.6%
Net Income
-204
Net Margin
-8.2%
EPS (Basic)
$-1.13
EPS (Diluted)
$-1.13
EBITDA
42
EBITDA Margin
1.7%

2022

12/31/2022

Revenue
2,084
Cost of Revenue
574
Gross Profit
1,510
Gross Margin
72.4%
Operating Income
-578
Operating Margin
-27.7%
Net Income
-624
Net Margin
-29.9%
EPS (Basic)
$-3.54
EPS (Diluted)
$-3.54
EBITDA
-387
EBITDA Margin
-18.6%

2021

12/31/2021

Revenue
1,767
Cost of Revenue
459
Gross Profit
1,308
Gross Margin
74.0%
Operating Income
-835
Operating Margin
-47.3%
Net Income
-596
Net Margin
-33.7%
EPS (Basic)
$-3.48
EPS (Diluted)
$-3.48
EBITDA
-618
EBITDA Margin
-35.0%

2020

12/31/2020

Revenue
1,491
Cost of Revenue
354
Gross Profit
1,137
Gross Margin
76.2%
Operating Income
-558
Operating Margin
-37.4%
Net Income
-849
Net Margin
-56.9%
EPS (Basic)
$-5.61
EPS (Diluted)
$-5.61
EBITDA
-633
EBITDA Margin
-42.4%